Premature rupture of membranes: signs and tactics

Premature rupture of membranes (PROM) is the rupture of the membranes before the onset of labor, occurring before 37 weeks of gestation. If the rupture occurs at or after term, it is called PROM (premature rupture of membranes) at ≥37 weeks; if it occurs before 37 weeks, it is called PPROM. [1]

PPROM occurs in approximately 2-4% of singleton pregnancies and is a leading cause of preterm birth and prematurity-related neonatal morbidity. The consequences for the fetus and mother depend on the gestational age at the time of rupture, the presence of infection, and the time between rupture and delivery. [2]

Clinically, PPROM is important because it challenges the risk of infectious complications during prolonged latency and the risk of prematurity during early obstetric intervention. This makes the management algorithm dependent on the specific gestational age and the condition of the mother and fetus. [3]

Key management goals are: 1) to minimize maternal and fetal infectious complications, 2) to optimize fetal outcomes by using lung maturation and neuroprotective agents where indicated, and 3) to make timely decisions about delivery when there is a threat to the mother or fetus. [4]

Depending on the clinical situation, either a "wait and see" strategy with monitoring, immediate induction, or cesarean section is used; the choice depends on the gestational age, clinical presentation, and local protocols. Current national and international guidelines provide clear guidelines but allow for individualization. [5]

Table 1. Key definitions and clinical tasks

Concept	Key idea
PPROM	Rupture of membranes before 37 weeks. [6]
Frequency	≈2-4% of singleton pregnancies. [7]
Main risks	Maternal infection, fetal prematurity. [8]
Objectives of management	Reducing infections, optimizing fetal maturity, and resolving the issue of delivery in a timely manner. [9]
Approach	Customized: Waiting or immediate delivery depending on time and condition. [10]

Etiology and risk factors of PPROM

PPROM is a multifactorial condition. Recognized risk factors include previous preterm birth and premature rupture of the fetus, cervical surgery, multiple pregnancies, vaginal and genitourinary infections, structural abnormalities of the placental site, and smoking.[11]

Urogenital infections and chronic inflammation of the fetal membranes are associated with an increased incidence of membrane rupture; microbial colonization can weaken the membrane tissue and trigger biochemical processes of collagen degradation. Therefore, the assessment and treatment of infections are included in the PPROM management algorithm. [12]

Other biopsychosocial factors—low socioeconomic status, poor nutrition, physical activity, and injuries—have also been associated with an increased risk of PPROM in population studies. These factors are often modifiable and amenable to preventive interventions. [13]

Certain genetic and matrix characteristics of connective tissue may predispose to reduced membrane strength; research in this area is ongoing and does not yet provide preventive solutions at the population level. [14]

Identification of risk factors in the anamnesis allows for the selection of a monitoring group in advance and more frequent screening and preventive measures in patients with increased risk. [15]

Table 2. Main risk factors for PPROM

Factor	Significance for practice
Previous preterm birth or PPROM	High risk of relapse; monitoring and planning. [16]
Vaginal and cervical infections	Diagnosis and treatment before and during pregnancy are important. [17]
Cervical procedures	After cone or conization the risk is higher; take this into account in planning. [18]
Multiple pregnancy	Increases stress and risk of PPROM. [19]
Smoking and poor nutrition	Modifiable factors requiring intervention.[20]

Diagnosis: How to Confirm Membranous Rupture

The diagnostic algorithm begins with a history and physical examination: complaints of leakage or a large volume of fluid, a speculum examination, and tests for the presence of fluid in the vaginal cavity. Specific tests include a ferning test on a glass slide, a nitrazine strip, and modern biochemical tests for PAMG-1 or IGFBP-1. [21]

Specialized tests (AmniSure - PAMG-1, Actim PROM - IGFBP-1) provide high sensitivity and specificity in case of equivocal results; however, interpretation must take into account the time since rupture and possible maternal contamination. Ultrasound to assess the amount of amniotic fluid and the position of the umbilical cord is a mandatory component of diagnosis. [22]

It is important to distinguish true leakage from increased vaginal discharge, cystitis, and small-volume premature leakage; if in doubt, observation and re-evaluation in the clinic are recommended. Routine vaginal culture and GBS testing are performed to assess the risk of infection and plan antibiotic prophylaxis.[23]

Laboratory markers of infection and inflammation (leukocytosis, C-reactive protein) are used to monitor the mother's condition, but their sensitivity and specificity in early infection are limited; clinical assessment remains the primary determinant. If signs of infection are present, urgent delivery is indicated. [24]

The diagnosis of PPROM must be made quickly and clearly - confirmation of membrane rupture moves the patient into a regime of more active monitoring, possible hospitalization and decisions about the administration of corticosteroids and antibiotics. [25]

Table 3. Diagnostic kit for suspected PPROM

Study	Target
Inspection in mirrors and assessment of leakage	Initial clinical assessment
Ferning and nitrazine test	Quick assessment (if in doubt) [26]
PAMG-1 or IGFBP-1	High sensitivity and specificity for ROM.[27]
Ultrasound - amniotic fluid index	Assessment of AFI and cord position. [28]
Bacterial cultures, GBS	Planning antibiotic prophylaxis and infection monitoring. [29]

Basic principles of management according to gestational age

PPROM management is divided into timeframes: up to 24 weeks (perivability period), 24+0-33+6 weeks (early period, where deferment is often preferable), 34+0-36+6 weeks (late preterm period). These boundaries determine different risks and strategies. [30]

Before 24 weeks, the decision on management requires an individualized approach and detailed consultation: there is a high risk of perinatal mortality, the development of pulmonary structures, and the risk of maternal infection. In many cases, options for both conservative management with expectation and termination of pregnancy are discussed. The role of transfers to high-intensity neonatology centers is critical. [31]

In the 24+0-33+6 week range, expectant management is most often chosen, with hospitalization, monitoring of the mother and fetus, and administration of corticosteroids for lung maturation and latency antibiotics; if signs of infection appear or worsen, delivery is recommended. The decision on hospitalization and the duration of the wait depends on the condition and resources. [32]

After 34 weeks, most guidelines favor intensifying and initiating labor, as the risks of prematurity are significantly reduced, while continued latency increases the risk of maternal and neonatal infection. Between 34 and 37 weeks, the decision is individualized, taking into account the mother's condition, examination results, and local protocols. [33]

In each time interval, the following algorithms must be clearly defined: indications for immediate delivery, criteria for hospitalization, antibiotic therapy regimen, prescription of corticosteroids and neuroprotective measures when indicated. [34]

Table 4. Generalized algorithm for maintaining PPROM by timeframe

Gestation	Recommended strategy
<24 weeks	Individualized decision; discussion of perinatal outcomes and transfer to a specialized center. [35]
24+0-33+6 weeks	Waiting in the absence of infection; corticosteroids; latent antibiotic therapy; monitoring. [36]
34+0-36+6 weeks	Most often - initiation of labor; individualization according to the clinic. [37]
Any term	Immediate delivery if chorioamnionitis is suspected or if the condition worsens. [38]

Medical interventions: corticosteroids, antibiotics, magnesium and tocolysis

Corticosteroids for fetal lung maturation are recommended for those at risk of delivery within the next 7 days between 24+0 and 34+0 weeks; standard regimens include betamethasone 12 mg intramuscularly every 24 hours for two doses or dexamethasone 6 mg intramuscularly every 12 hours for four doses. The decision to repeat the course should be made cautiously and in accordance with protocols. [39]

Latent antibiotic therapy is indicated for PPROM up to 34 weeks to prolong the latency interval and reduce the risk of neonatal infection. The classic ACOG regimen is 48 hours of intravenous ampicillin with erythromycin, followed by 5 days of oral amoxicillin and erythromycin. Separate intrapartum antibiotic prophylaxis is administered for the prevention of group B streptococcus when indicated. [40]

Magnesium sulfate for fetal neuroprotection is recommended for those at risk of delivery within 24 hours of the gestational window where benefit has been demonstrated (usually for delivery before 32-34 weeks, depending on guidelines); the regimen and thresholds depend on local protocol recommendations and international organizations. Magnesium is administered using the standard parenteral regimen under maternal monitoring. [41]

Tocolytics are not routinely recommended for PPROM because suppression of labor may increase the risk of maternal and fetal infection; their use may be considered in exceptional situations to complete a course of corticosteroids under strict indications and supervision. [42]

All drug interventions should be performed taking into account contraindications, laboratory monitoring and local protocols; detailed documentation of the date and time of administration is important for subsequent management. [43]

Table 5. Drug therapy for PPROM - briefly

Intervention	When shown	Examples of diagrams
Corticosteroids	Risk of giving birth in the next 7 days, 24+0-34+0 weeks [44]	Betamethasone 12 mg IM ×2; dexamethasone 6 mg IM ×4.
Latent antibiotics	PPROM <34 weeks when expecting delivery. [45]	IV ampicillin + IV erythromycin 48 hours → PO amoxicillin + PO erythromycin 5 days. [46]
Intrapartum GBS prophylaxis	Positive GBS or unknown status at delivery	Intrapartum antibiotic prophylaxis according to a local protocol. [47]
Magnesium for neuroprotection	Risk of delivery <24 hours at <32−34 weeks.	Dose according to clinical protocol; maternal monitoring. [48]
Tocolysis	Generally not recommended for PPROM	Exceptional cases, control infection risk. [49]

Indications for immediate delivery and red flags

Immediate delivery is indicated in cases of clinical suspicion of chorioamnionitis, bleeding, severe maternal respiratory or cardiovascular failure, uncompensated fetal cardiac dysfunction, or uncontrolled fetal hypoxia. These conditions require urgent intervention regardless of gestational age. [50]

Signs of chorioamnionitis include maternal fever, maternal and/or fetal tachycardia, uterine tenderness, and abnormal laboratory markers of inflammation. If these occur, urgent delivery and intravenous antibiotic therapy are indicated. [51]

With the progression of spontaneous labor with regular contractions and signs of cervical dilation, a decision is also made about delivery; the choice of the method of delivery is dictated by the clinical situation. [52]

An attempt at emergency delivery of the fetus is also indicated in cases of severe intrauterine infection or when expectant management is ineffective and the risk of complications increases. Medical documentation and the mother's informed consent are critical in these situations. [53]

Each of these conditions requires rapid communication between the obstetrician, anesthesiologist, and neonatologist to ensure safe delivery and subsequent care of the newborn. [54]

Table 6. "Red flags" - indications for immediate delivery

Sign	Action
Suspected chorioamnionitis	Urgent delivery; intravenous antibiotic therapy. [55]
Massive bleeding	Immediate pricing and delivery. [56]
Maternal or fetal instability	Urgent delivery in a hospital setting. [57]
Progressive labor	Continue delivery depending on the condition. [58]

Complications for mother and newborn, prognosis

Maternal complications include chorioamnionitis, postpartum endometritis, sepsis, and, less commonly, obstetric hemorrhage and the need for hysterectomy in severe infections. The risk of complications increases with prolonged latency and in the presence of pathogen colonization.[59]

Neonatal risks are directly related to gestational age: prematurity leads to respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, and prolonged neonatal intensive care. Early hospitalization and training of the neonatal team improve outcomes. [60]

Timely administration of corticosteroids, latency antibiotics and neuroprotective measures reduces the risks of neonatal morbidity and mortality at certain times; this makes an adequate clinical response a key factor in outcome. [61]

Long-term outcomes of the child depend on the degree of prematurity and complications in the neonatal period; early interventions of resuscitation and intensive care, as well as subsequent developmental monitoring are important to improve the prognosis. [62]

Psychosocial support is also important for the mother: PPROM and the risk of preterm birth are stress factors that require information, transparency of treatment and provision of support. [63]

Table 7. Main complications and measures to reduce them

Complication	Prevention/mitigation measures
Chorioamnionitis	Infection control, timely delivery if signs appear. [64]
Neonatal sepsis	Latent antibiotics, training of neonatologists. [65]
Respiratory failure	Corticosteroids, neonatal resuscitation. [66]
Neurological involvement	Magnesium for neuroprotection in the indicated timeframes. [67]
Psychological stress	Counseling and support for parents. [68]

Prevention, planning and information support for the patient

Prevention of PPROM is partly possible through reducing modifiable factors: smoking cessation, early diagnosis and treatment of vaginal infections, nutritional optimization, and management of chronic diseases. For women at high risk, strategic decisions and monitoring in specialized centers are discussed. [69]

In women with previous PPROM or preterm labor, preventive measures are considered, including infection control, discussion of indications for cervical cerclage, and surveillance programs. The role of progesterone in preventing previous preterm labor exists for certain groups, but specific prevention of PPROM requires an individualized approach. [70]

Educating the patient is key: discuss the signs of leakage, the action plan if symptoms occur, potential treatment options, and possible outcomes depending on the time frame. A clear "action plan" reduces anxiety and facilitates timely treatment if the condition worsens. [71]

Organizationally, it's crucial to consider logistics in advance: where to transfer a patient with early PPROM, which center can provide intensive neonatal care, and how to quickly organize transportation and a team of specialists. This is especially critical in regions with limited resources. [72]

Finally, documenting discussions and informed consent increases transparency of the process and helps families make informed decisions in complex clinical situations. [73]